Procept BioRobotics [PRCT] vs Artivion [AORT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Procept BioRobotics Corporation wins in 5 metrics, Artivion Inc. wins in 14 metrics, with 0 ties. Artivion Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Procept BioRobotics Corporation Artivion Inc. Better
P/E Ratio (TTM) -14.09 179.71 Artivion Inc.
Price-to-Book Ratio 3.86 4.03 Procept BioRobotics Corporation
Debt-to-Equity Ratio 21.45 57.67 Procept BioRobotics Corporation
PEG Ratio -0.27 -1.59 Procept BioRobotics Corporation
EV/EBITDA -12.39 36.67 Artivion Inc.
Profit Margin (TTM) -31.02% 2.21% Artivion Inc.
Operating Margin (TTM) -40.64% 8.09% Artivion Inc.
EBITDA Margin (TTM) N/A 8.09% N/A
Return on Equity -24.89% 2.70% Artivion Inc.
Return on Assets (TTM) -12.46% 2.34% Artivion Inc.
Free Cash Flow (TTM) $-58.34M $839,000 Artivion Inc.
Dividend Yield 0.64% N/A N/A
1-Year Return -54.60% -24.98% Artivion Inc.
Price-to-Sales Ratio (TTM) 4.59 4.15 Artivion Inc.
Enterprise Value $1.21B $1.97B Artivion Inc.
EV/Revenue Ratio 3.92 4.47 Procept BioRobotics Corporation
Gross Profit Margin (TTM) 60.63% 63.06% Artivion Inc.
Revenue per Share (TTM) $6 $10 Artivion Inc.
Earnings per Share (Diluted) $-1.72 $0.21 Artivion Inc.
Beta (Stock Volatility) 0.93 1.62 Procept BioRobotics Corporation
Short % of Float 12.30% 4.13% Artivion Inc.

Procept BioRobotics Corporation vs Artivion Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics Corporation-1.61%-0.49%6.04%0.27%-20.64%-14.40%
Artivion Inc.0.78%-9.58%-42.08%-46.71%-54.75%-53.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics Corporation-54.60%-18.98%-34.18%-34.18%-34.18%-34.18%
Artivion Inc.-24.98%45.13%-23.19%88.21%317.89%366.18%

Performance & Financial Health Analysis: Procept BioRobotics Corporation vs Artivion Inc.

MetricPRCTAORT
Market Information
Market Cap i$1.37B$1.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i961,942273,552
90 Day Avg. Volume i1,216,347406,554
Last Close$26.33$20.58
52 Week Range$19.35 - $66.85$19.16 - $48.25
% from 52W High-60.61%-57.35%
All-Time High$103.81 (Nov 11, 2024)$48.25 (Dec 17, 2025)
% from All-Time High-74.64%-57.35%
Growth Metrics
Quarterly Revenue Growth0.12%0.19%
Quarterly Earnings Growth0.12%0.19%
Financial Health
Profit Margin (TTM) i-0.31%0.02%
Operating Margin (TTM) i-0.41%0.08%
Return on Equity (TTM) i-0.25%0.03%
Debt to Equity (MRQ) i21.4557.67
Cash & Liquidity
Book Value per Share (MRQ)$6.50$9.37
Cash per Share (MRQ)$5.08$1.36
Operating Cash Flow (TTM) i$-48,985,000$39.88M
Levered Free Cash Flow (TTM) i$-23,916,124$-20,097,624
Dividends
Last 12-Month Dividend Yield i0.64%N/A
Last 12-Month Dividend i$0.38$0.00

Valuation & Enterprise Metrics Analysis: Procept BioRobotics Corporation vs Artivion Inc.

MetricPRCT (Apr 24, 2026)AORT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-14.09179.71
Forward P/E i-28.3832.65
PEG Ratio i-0.27-1.59
Price to Sales (TTM) i4.594.15
Price to Book (MRQ) i3.864.03
Market Capitalization
Market Capitalization i$1.37B$1.83B
Enterprise Value i$1.21B$1.97B
Enterprise Value Metrics
Enterprise to Revenue i3.924.47
Enterprise to EBITDA i-12.3936.67
Risk & Other Metrics
Beta i0.931.62
Book Value per Share (MRQ) i$6.50$9.37

Financial Statements Comparison: Procept BioRobotics Corporation vs Artivion Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPRCT (2025)AORT (2025)
Revenue/Sales i308.05M441.33M
Cost of Goods Sold i111.83M157.10M
COGS % of Revenue i36.3%35.6%
Gross Profit i196.23M284.23M
Gross Margin i63.7%64.4%
Research & Development i71.28M30.99M
Operating Income (EBIT) i-103.86M26.75M
Operating Margin i-33.7%6.1%
EBITDA i-85.41M59.48M
EBITDA Margin i-27.7%13.5%
Pre-Tax Income i-95.38M14.78M
Pre-Tax Income % of Revenue i-31.0%3.3%
Income Tax i190,0005.01M
Income Tax % of Revenue i0.1%1.1%
Net Income (Profit) i-95.57M9.77M
Profit Margin i-31.0%2.2%

Balance Sheet & Liquidity Metrics

MetricPRCT (2025)AORT (2025)
Cash & Equivalents i286.50M64.91M
Total Current Assets i450.38M358.08M
Total Current Assets % of Revenue i146.2%81.1%
Total Current Liabilities i65.80M101.56M
Total Current Liabilities % of Revenue i21.4%23.0%
Long-Term Debt i76.27M252.24M
Long-Term Debt % of Revenue i24.8%57.2%
Total Shareholders Equity i365.87M448.23M
Retained Earnings i-641.56M-51.50M
Retained Earnings % of Revenue i-208.3%-11.7%
Property, Plant & Equipment i21.51M34.70M

Cash Flow Statement Comparison

MetricPRCT (2025)AORT (2025)
Operating Cash Flow i-50.56M41.11M
Operating Cash Flow % of Revenue i-16.4%9.3%
Capital Expenditures i-9.36MN/A
Free Cash Flow i-58.34M839,000
FCF Margin i-18.9%0.2%
Debt Repayment iN/A-2.46M
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricPRCTAORT
Shares Short i5.87M1.67M
Short Ratio i3.254.28
Short % of Float i12.30%4.13%
Shares Outstanding i56.32M47.84M
Float Shares i55.12M45.40M
% Held by Insiders i3.22%4.52%
% Held by Institutions i104.61%91.48%
% Held by Public i-7.83%4.00%

Dividend Analysis & Yield Comparison: Procept BioRobotics Corporation vs Artivion Inc.

MetricPRCTAORT
Last 12-Month Dividend i$0.38$0.00
Last 12-Month Dividend Yield i0.64%N/A
3-Year Avg Annual Dividend i$0.53$0.00
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$1.59$0.00
Ex-Dividend DateMar 31, 2025N/A